OpenURL Connection Search

Select item for more details and to access through your institution.

WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models.
Published in:
Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad066
By:
- Conage-Pough, Jason E;
- Stopka, Sylwia A;
- Oh, Ju-Hee;
- Mladek, Ann C;
- Burgenske, Danielle M;
- Regan, Michael S;
- Baquer, Gerard;
- Decker, Paul A;
- Carlson, Brett L;
- Bakken, Katrina K;
- Zhang, Jinqiang;
- Liu, Lily;
- Sun, Claire;
- Mu, Zhihua;
- Zhong, Wei;
- Tran, Nhan L;
- Elmquist, William F;
- Agar, Nathalie Y R;
- Sarkaria, Jann N;
- White, Forest M
Publication type:
Article
Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts.
Published in:
Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac130
By:
- Porath, Kendra A.;
- Regan, Michael S.;
- Griffith, Jessica I.;
- Jain, Sonia;
- Stopka, Sylwia A.;
- Burgenske, Danielle M.;
- Bakken, Katrina K.;
- Carlson, Brett L.;
- Decker, Paul A.;
- Vaubel, Rachael A.;
- Dragojevic, Sonja;
- Mladek, Ann C.;
- Connors, Margaret A.;
- Zeng Hu;
- Lihong He;
- Kitange, Gaspar J.;
- Gupta, Shiv K.;
- Feldsien, Thomas M.;
- Lefebvre, Didier R.;
- Agar, Nathalie Y. R.
Publication type:
Article
Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin—a novel tumor checkpoint controller targeting microtubules.
Published in:
Neuro-Oncology, 2022, v. 24, n. 3, p. 384, doi. 10.1093/neuonc/noab162
By:
- Burgenske, Danielle M;
- Talele, Surabhi;
- Pokorny, Jenny L;
- Mladek, Ann C;
- Bakken, Katrina K;
- Carlson, Brett L;
- Schroeder, Mark A;
- He, Lihong;
- Hu, Zeng;
- Gampa, Gautham;
- Kosel, Matthew L;
- Decker, Paul A;
- Kitange, Gaspar J;
- Schmitt-Hoffmann, Anne;
- Bachmann, Felix;
- Vaubel, Rachael A;
- Eckel-Passow, Jeanette E;
- Giannini, Caterina;
- McSheehy, Paul;
- Lane, Heidi A
Publication type:
Article
Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization.
Published in:
Science Translational Medicine, 2024, v. 16, n. 734, p. 1, doi. 10.1126/scitranslmed.adj5962
By:
- Chen, Jiajia;
- Laverty, Daniel J.;
- Talele, Surabhi;
- Bale, Ashwin;
- Carlson, Brett L.;
- Porath, Kendra A.;
- Bakken, Katrina K.;
- Burgenske, Danielle M.;
- Decker, Paul A.;
- Vaubel, Rachael A.;
- Eckel-Passow, Jeanette E.;
- Bhargava, Rohit;
- Lou, Zhenkun;
- Hamerlik, Petra;
- Harley, Brendan;
- Elmquist, William F.;
- Nagel, Zachary D.;
- Gupta, Shiv K.;
- Sarkaria, Jann N.
Publication type:
Article
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma.
Published in:
2016
By:
- Gupta, Shiv K.;
- Kizilbash, Sani H.;
- Carlson, Brett L.;
- Mladek, Ann C.;
- Boakye-Agyeman, Felix;
- Bakken, Katrina K.;
- Pokorny, Jenny L.;
- Schroeder, Mark A.;
- Decker, Paul A.;
- Ling Cen;
- Eckel-Passow, Jeanette E.;
- Sarkar, Gobinda;
- Ballman, Karla V.;
- Reid, Joel M.;
- Jenkins, Robert B.;
- Verhaak, Roeland G.;
- Sulman, Erik P.;
- Kitange, Gaspar J.;
- Sarkaria, Jann N.;
- Cen, Ling
Publication type:
journal article

Found: 5

WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models.

Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts.

Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin—a novel tumor checkpoint controller targeting microtubules.

Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization.

Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma.